Murchinson Ltd. Inhibikase Therapeutics, Inc. Transaction History

Murchinson Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.03 - $1.77 $227,575 - $391,076	-220,947 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.38 - $2.17 $138,000 - $217,000	-100,000 Reduced 31.16%	220,947 $327,000
Q2 2021 Aug 13, 2021	BUY	$2.8 - $6.23 $898,651 - $2 Million	320,947 New	320,947 $899,000

1.03M

Ticker IKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,227,100
Market Cap $30.8M
Description
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointes...

Get notified when there are updates to the investment portfolio of Murchinson Ltd., based on Form 13F filings with the SEC.

Stay updated on Murchinson Ltd. with notifications on news.